Central Pharmaceutical Jsc No. 3 (DP3)
DP3: Công bố thông tin quyết định xử phạt vi phạm hành chính về thuế
Earlier from Central Pharmaceutical Jsc No. 3
- Central Pharmaceutical Joint Stock Company No3: 2024 net revenue rose 1.9% and gross margin improved, but net profit slipped 3.3%
- Central Pharmaceutical Joint Stock Company No3: Q3 2024 delivered higher profit and margin, but nine-month results reflect ongoing market headwinds
- Central Pharmaceutical Joint Stock Company No3: H1 2024 saw lower profit and revenue, but improved cash and zero borrowings
- 22/09/2023, first trading day of additional listed shares